1
|
Toma A, Dos Santos C, Burzyńska B, Góra M, Kiliszek M, Stickle N, Kirsten H, Kosyakovsky L, Wang B, van Diepen S, Epelman S, Szekely Y, Marshall JC, Billia F, Lawler PR. Diversity in the Expressed Genomic Host Response to Myocardial Infarction. Circ Res 2022; 131:106-108. [PMID: 35534922 DOI: 10.1161/circresaha.121.318391] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Affiliation(s)
- Augustin Toma
- Peter Munk Cardiac Centre, Toronto General Hospital, Canada (A.T., B.W., S.E., Y.S., F.B., P.R.L.).,Department of Medicine (A.T., C.d.S., B.W., S.E., Y.S., F.B., P.R.L.)
| | - Claudia Dos Santos
- Department of Medicine (A.T., C.d.S., B.W., S.E., Y.S., F.B., P.R.L.).,Interdepartmental Division of Critical Care Medicine, University of Toronto, Canada. (C.d.S., J.C.M., P.R.L.).,St Michael's Hospital, Toronto, Canada (C.d.S., J.C.M.)
| | - Beata Burzyńska
- Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland (B.B., M.G.)
| | - Monika Góra
- Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland (B.B., M.G.)
| | - Marek Kiliszek
- Department of Cardiology and Internal Diseases, Military Institute of Medicine, Warsaw, Poland (M.K.)
| | | | - Holger Kirsten
- LIFE - Leipzig Research Center for Civilization Diseases and Institute for Medical Informatics, Statistics and Epidemiology, Universität Leipzig, Germany (H.K.)
| | - Leah Kosyakovsky
- Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, MA (L.K.)
| | - Bo Wang
- Peter Munk Cardiac Centre, Toronto General Hospital, Canada (A.T., B.W., S.E., Y.S., F.B., P.R.L.).,Department of Medicine (A.T., C.d.S., B.W., S.E., Y.S., F.B., P.R.L.)
| | - Sean van Diepen
- Division of Cardiology, Department of Critical Care, Department of Medicine, University of Alberta, Edmonton, Canada (S.v.D.)
| | - Slava Epelman
- Peter Munk Cardiac Centre, Toronto General Hospital, Canada (A.T., B.W., S.E., Y.S., F.B., P.R.L.).,Department of Medicine (A.T., C.d.S., B.W., S.E., Y.S., F.B., P.R.L.).,Ted Rogers Centre for Heart Research, Toronto, Canada (S.E., F.B., P.R.L.)
| | - Yishay Szekely
- Peter Munk Cardiac Centre, Toronto General Hospital, Canada (A.T., B.W., S.E., Y.S., F.B., P.R.L.).,Department of Medicine (A.T., C.d.S., B.W., S.E., Y.S., F.B., P.R.L.)
| | - John C Marshall
- Interdepartmental Division of Critical Care Medicine, University of Toronto, Canada. (C.d.S., J.C.M., P.R.L.).,St Michael's Hospital, Toronto, Canada (C.d.S., J.C.M.)
| | - Filio Billia
- Peter Munk Cardiac Centre, Toronto General Hospital, Canada (A.T., B.W., S.E., Y.S., F.B., P.R.L.).,Department of Medicine (A.T., C.d.S., B.W., S.E., Y.S., F.B., P.R.L.).,Ted Rogers Centre for Heart Research, Toronto, Canada (S.E., F.B., P.R.L.)
| | - Patrick R Lawler
- Peter Munk Cardiac Centre, Toronto General Hospital, Canada (A.T., B.W., S.E., Y.S., F.B., P.R.L.).,Department of Medicine (A.T., C.d.S., B.W., S.E., Y.S., F.B., P.R.L.).,Interdepartmental Division of Critical Care Medicine, University of Toronto, Canada. (C.d.S., J.C.M., P.R.L.).,Ted Rogers Centre for Heart Research, Toronto, Canada (S.E., F.B., P.R.L.)
| |
Collapse
|
2
|
Scholz M, Henger S, Beutner F, Teren A, Baber R, Willenberg A, Ceglarek U, Pott J, Burkhardt R, Thiery J. Cohort Profile: The Leipzig Research Center for Civilization Diseases–Heart Study (LIFE-Heart). Int J Epidemiol 2020; 49:1439-1440h. [DOI: 10.1093/ije/dyaa075] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2020] [Accepted: 04/06/2020] [Indexed: 12/12/2022] Open
Affiliation(s)
- Markus Scholz
- Institute for Medical Informatics, Statistic and Epidemiology, University of Leipzig, Leipzig, Germany
- Leipzig Research Center for Civilization Diseases (LIFE), University of Leipzig, Leipzig, Germany
| | - Sylvia Henger
- Institute for Medical Informatics, Statistic and Epidemiology, University of Leipzig, Leipzig, Germany
- Leipzig Research Center for Civilization Diseases (LIFE), University of Leipzig, Leipzig, Germany
| | - Frank Beutner
- Leipzig Research Center for Civilization Diseases (LIFE), University of Leipzig, Leipzig, Germany
- Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University Hospital Leipzig, Leipzig, Germany
- Heart Center Leipzig, Leipzig, Germany
| | - Andrej Teren
- Leipzig Research Center for Civilization Diseases (LIFE), University of Leipzig, Leipzig, Germany
- Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University Hospital Leipzig, Leipzig, Germany
- Heart Center Leipzig, Leipzig, Germany
| | - Ronny Baber
- Leipzig Research Center for Civilization Diseases (LIFE), University of Leipzig, Leipzig, Germany
- Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University Hospital Leipzig, Leipzig, Germany
| | - Anja Willenberg
- Leipzig Research Center for Civilization Diseases (LIFE), University of Leipzig, Leipzig, Germany
- Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University Hospital Leipzig, Leipzig, Germany
| | - Uta Ceglarek
- Leipzig Research Center for Civilization Diseases (LIFE), University of Leipzig, Leipzig, Germany
- Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University Hospital Leipzig, Leipzig, Germany
| | - Janne Pott
- Institute for Medical Informatics, Statistic and Epidemiology, University of Leipzig, Leipzig, Germany
- Leipzig Research Center for Civilization Diseases (LIFE), University of Leipzig, Leipzig, Germany
| | - Ralph Burkhardt
- Leipzig Research Center for Civilization Diseases (LIFE), University of Leipzig, Leipzig, Germany
- Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University Hospital Leipzig, Leipzig, Germany
- Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany
| | - Joachim Thiery
- Leipzig Research Center for Civilization Diseases (LIFE), University of Leipzig, Leipzig, Germany
- Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University Hospital Leipzig, Leipzig, Germany
| |
Collapse
|
3
|
Whole blood transcriptome profile at hospital admission discriminates between patients with ST-segment elevation and non-ST-segment elevation acute myocardial infarction. Sci Rep 2020; 10:8731. [PMID: 32457432 PMCID: PMC7250845 DOI: 10.1038/s41598-020-65527-7] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/21/2020] [Accepted: 05/06/2020] [Indexed: 12/20/2022] Open
Abstract
Whether ST-segment (STEMI) and non-ST-segment elevation myocardial infarction (NSTEMI) should be regarded as distinct pathophysiological entities is a matter of debate. We tested the hypothesis that peripheral blood gene-expression profiles at presentation distinguish STEMI from NSTEMI. We performed a case-control study collecting whole-blood from 60 STEMI and 58 NSTEMI (defined according to the third universal definition of MI) consecutive patients on hospital admission. We used RNA-sequencing for the discovery phase, comparing 15 STEMI vs. 15 NSTEMI patients, matched for age, sex, and cardiovascular risk factors, and quantitative PCR in the remaining unmatched patients for validating top-significant genes. Gene-level differential expression analysis identified significant differences in the expression of 323 genes: 153 genes withstood correction for admission cardiac troponin I (cTnI), differentiating the two conditions independently of myocardial necrosis extent. Functional annotation analysis uncovered divergent modulation in leukocyte and platelet activation, cell migration, and mitochondrial respiratory processes. Linear regression analysis revealed gene expression patterns on admission predicting infarct size, as indexed by cTnI peak (R2 = 0.58–0.75). Our results unveil distinctive pathological traits for these two MI subtypes and provide insights into the early assessment of injury extent. This could translate into RNA-based disease-specific biomarkers for precision diagnosis and risk stratification.
Collapse
|
4
|
Konijnenberg LSF, Damman P, Duncker DJ, Kloner RA, Nijveldt R, van Geuns RJM, Berry C, Riksen NP, Escaned J, van Royen N. Pathophysiology and diagnosis of coronary microvascular dysfunction in ST-elevation myocardial infarction. Cardiovasc Res 2020; 116:787-805. [PMID: 31710673 PMCID: PMC7061278 DOI: 10.1093/cvr/cvz301] [Citation(s) in RCA: 108] [Impact Index Per Article: 27.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/25/2019] [Revised: 10/13/2019] [Accepted: 11/06/2019] [Indexed: 12/15/2022] Open
Abstract
Early mechanical reperfusion of the epicardial coronary artery by primary percutaneous coronary intervention (PCI) is the guideline-recommended treatment for ST-elevation myocardial infarction (STEMI). Successful restoration of epicardial coronary blood flow can be achieved in over 95% of PCI procedures. However, despite angiographically complete epicardial coronary artery patency, in about half of the patients perfusion to the distal coronary microvasculature is not fully restored, which is associated with increased morbidity and mortality. The exact pathophysiological mechanism of post-ischaemic coronary microvascular dysfunction (CMD) is still debated. Therefore, the current review discusses invasive and non-invasive techniques for the diagnosis and quantification of CMD in STEMI in the clinical setting as well as results from experimental in vitro and in vivo models focusing on ischaemic-, reperfusion-, and inflammatory damage to the coronary microvascular endothelial cells. Finally, we discuss future opportunities to prevent or treat CMD in STEMI patients.
Collapse
Affiliation(s)
- Lara S F Konijnenberg
- Department of Cardiology, Radboud University Medical Center, Postbus 9101, 6500 HB Nijmegen, The Netherlands
| | - Peter Damman
- Department of Cardiology, Radboud University Medical Center, Postbus 9101, 6500 HB Nijmegen, The Netherlands
| | - Dirk J Duncker
- Department of Radiology and Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands
| | - Robert A Kloner
- Huntington Medical Research Institutes, Pasadena, CA, USA
- Division of Cardiovascular Medicine, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
| | - Robin Nijveldt
- Department of Cardiology, Radboud University Medical Center, Postbus 9101, 6500 HB Nijmegen, The Netherlands
| | - Robert-Jan M van Geuns
- Department of Cardiology, Radboud University Medical Center, Postbus 9101, 6500 HB Nijmegen, The Netherlands
| | - Colin Berry
- West of Scotland Heart and Lung Centre, Golden Jubilee National Hospital, Clydebank, UK
- British Heart Foundation, Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK
| | - Niels P Riksen
- Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
| | - Javier Escaned
- Department of Cardiology, Hospital Clínico San Carlos IDISSC, Universidad Complutense de Madrid, Madrid, Spain
| | - Niels van Royen
- Department of Cardiology, Radboud University Medical Center, Postbus 9101, 6500 HB Nijmegen, The Netherlands
| |
Collapse
|